According to Verve Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.23 B. In 2022 the company made an earning of -$0.17 B a decrease over its 2021 earnings that were of -$87.07 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.23 B | 34.67% |
2022 | -$0.17 B | 90.3% |
2021 | -$87.07 M | 114.31% |
2020 | -$40.63 M |